Metastatic Bone Disease Market Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2017 - 2026

Jun 2018| TMR719A| Transparency

Report Highlights

Global Metastatic Bone Disease Market: Overview
This report analyzes the current and future scenario of the global metastatic bone disease market. Rise in incidence rate of cancer across the world, favorable reimbursement scenario, stringent regulatory policies assuring better product quality, increase in cancer research funding and new drug approvals, and surge in cancer awareness programs by governments and patient support organizations drive the global metastatic bone disease market. The global market has been segmented based on treatment, origin of metastasis, end-user, and region.

The global metastatic bone disease market report comprises an elaborate executive summary, which includes a snapshot that provides information about various segments of the market. It also provides information and data analysis of the global market with respect to the segments based on treatment, origin of metastasis, end-user, and region. A detailed qualitative analysis of drivers and restraints of the market and opportunities has been provided in the overview section. Additionally, the section comprises competitive matrix and company profiles along with business overview to understand the competitive landscape in the market. This section of the report also provides market attractiveness analysis by region and market share analysis by key players, thereby presenting a thorough analysis of the overall competitive scenario in the metastatic bone disease market.

Global Metastatic Bone Disease Market: Key Segments
Based on treatment, the global metastatic bone disease market has been segmented into medication, radiation therapy, surgical intervention, and tumor ablation therapy. The medication segment has been classified into chemotherapy, hormone therapy, bisphosphonates, opiate therapy, and immunotherapy. The market size and forecast for each of these segments have been provided for the period from 2016 to 2026, along with their respective CAGRs for the forecast period from 2018 to 2026, considering 2017 as the base year.

Based on origin of metastasis, the global metastatic bone disease market has been divided into breast, lung, thyroid, kidney, prostate, and others. The market size and forecast for each of these segments have been provided for the period from 2016 to 2026, along with their respective CAGRs for the forecast period from 2018 to 2026, considering 2017 as the base year.

In terms of end-user, the global the global metastatic bone disease market has been categorized into hospitals, specialty clinics, and ambulatory surgical centers. The segments have been analyzed based on health care infrastructure, government investment, and economic development in the regions. The market size and forecast for each of these segments have been provided for the period from 2016 to 2026, along with their respective CAGRs for the forecast period from 2018 to 2026, considering 2017 as the base year.

Global Metastatic Bone Disease Market: Regional Outlook
Geographically, the global metastatic bone disease market has been segmented into five major regions and the key countries in the respective region: North America (the U.S. and Canada), Europe (the U.K., Germany, France, Spain, Italy, and Rest of Europe), Asia Pacific (India, China, Japan, and Rest of Asia Pacific), Latin America (Mexico, Brazil, and Rest of Latin America) and Middle East & Africa (South Africa, GCC Countries, and Rest of Middle East & Africa). The market size and forecast for each of these regions and the mentioned countries have been provided for the period from 2016 to 2026, along with their respective CAGRs for the forecast period from 2018 to 2026, considering 2017 as the base year. The research study also covers the competitive scenario in these regions.

Companies Mentioned in the Report
The report also profiles the major players in the market in terms of various attributes such as company overview, financial overview, product portfolio, business strategies, and recent developments. Major players operating in the global metastatic bone disease market are Amgen, Inc., Merck & Co., Inc., F. Hoffmann-La Roche Ltd., Novartis AG, Eli Lilly and Company, Bayer AG, Fresenius Kabi AG, BTG plc, Boston Scientific Corporation, and Medtronic. These players are adopting organic and inorganic growth strategies to expand product offerings, strengthen geographical reach, increase customer base, and garner market share.

The global metastatic bone disease market has been segmented as follows:

Global Metastatic Bone Disease Market, by Treatment
Medication
Chemotherapy
Hormone Therapy
Bisphosphonates
Opiate Therapy
Immunotherapy
Radiation Therapy
Surgical Intervention
Tumor Ablation Therapy

Global Metastatic Bone Disease Market, by Origin of Metastasis
Breast
Lung
Thyroid
Kidney
Prostate
Others

Global Metastatic Bone Disease Market, by End-user
Hospitals
Specialty Clinics
Ambulatory Surgical Centers

Global Metastatic Bone Disease Market, by Region
North America
U.S.
Canada
Europe
Germany
U.K.
France
Italy
Spain
Rest of Europe
Asia Pacific
India
Japan
China
Rest of Asia Pacific
Latin America
Brazil
Mexico
Rest of Latin America
Middle East & Africa
South Africa
GCC Countries
Rest of Middle East & Africa

  • Table 1 : Global Metastatic Bone Disease Market Revenue (US$ Mn) Forecast, by Treatment, 2016–2026
  • Table 2 : Global Metastatic Bone Disease Market Revenue (US$ Mn) Forecast, by Medication, 2016–2026
  • Table 3 : Global Metastatic Bone Disease Market Revenue (US$ Mn) Forecast, by Origin of Metastasis, 2016–2026
  • Table 4 : Global Metastatic Bone Disease Market Revenue (US$ Mn) Forecast, by End-user, 2016–2026
  • Table 5 : Global Metastatic Bone Disease Market Revenue (US$ Mn) Forecast, by Region, 2016–2026
  • Table 6 : North America Metastatic Bone Disease Market Revenue (US$ Mn) Forecast, by Country, 2016–2026
  • Table 7 : North America Metastatic Bone Disease Market Revenue (US$ Mn) Forecast, by Treatment, 2016–2026
  • Table 8 : North America Metastatic Bone Disease Market Revenue (US$ Mn) Forecast, by Medication, 2016–2026
  • Table 9 : North America Metastatic Bone Disease Market Revenue (US$ Mn) Forecast, by Origin of Metastasis, 2016–2026
  • Table 10 : North America Metastatic Bone Disease Market Revenue (US$ Mn) Forecast, by End-user, 2016–2026
  • Table 11 : Europe Metastatic Bone Disease Market Revenue (US$ Mn) Forecast, by Country/Sub-region, 2016–2026
  • Table 12 : Europe Metastatic Bone Disease Market Revenue (US$ Mn) Forecast, by Treatment, 2016–2026
  • Table 13 : Europe Metastatic Bone Disease Market Revenue (US$ Mn) Forecast, by Medication, 2016–2026
  • Table 14 : Europe Metastatic Bone Disease Market Revenue (US$ Mn) Forecast, by Origin of Metastasis, 2016–2026
  • Table 15 : Europe Metastatic Bone Disease Market Revenue (US$ Mn) Forecast, by End-user, 2016–2026
  • Table 16 : Asia Pacific Metastatic Bone Disease Market Revenue (US$ Mn) Forecast, by Country/Sub-region, 2016–2026
  • Table 17 : Asia Pacific Metastatic Bone Disease Market Revenue (US$ Mn) Forecast, by Treatment, 2016–2026
  • Table 18 : Asia Pacific Metastatic Bone Disease Market Revenue (US$ Mn) Forecast, by Medication, 2016–2026
  • Table 19 : Asia Pacific Metastatic Bone Disease Market Revenue (US$ Mn) Forecast, by Origin of Metastasis, 2016–2026
  • Table 20 : Asia Pacific Metastatic Bone Disease Market Revenue (US$ Mn) Forecast, by End-user, 2016–2026
  • Table 21 : Latin America Metastatic Bone Disease Market Revenue (US$ Mn) Forecast, by Country/Sub-region, 2016–2026
  • Table 22 : Latin America Metastatic Bone Disease Market Revenue (US$ Mn) Forecast, by Treatment, 2016–2026
  • Table 23 : Latin America Metastatic Bone Disease Market Revenue (US$ Mn) Forecast, by Medication, 2016–2026
  • Table 24 : Latin America Metastatic Bone Disease Market Revenue (US$ Mn) Forecast, by Origin of Metastasis, 2016–2026
  • Table 25 : Latin America Metastatic Bone Disease Market Revenue (US$ Mn) Forecast, by End-user, 2016–2026
  • Table 26 : Middle East & Africa Metastatic Bone Disease Market Revenue (US$ Mn) Forecast, by Country/Sub region, 2016–2026
  • Table 27 : Middle East & Africa Metastatic Bone Disease Market Revenue (US$ Mn) Forecast, by Treatment, 2016–2026
  • Table 28 : Middle East & Africa Metastatic Bone Disease Market Revenue (US$ Mn) Forecast, by Medication, 2016–2026
  • Table 29 : Middle East & Africa Metastatic Bone Disease Market Revenue (US$ Mn) Forecast, by Origin of Metastasis, 2016–2026
  • Table 30 : Middle East & Africa Metastatic Bone Disease Market Revenue (US$ Mn) Forecast, by End-user, 2016–2026
  • Figure 1 : Global Metastatic Bone Disease Market Size (US$ Mn) and Distribution (%), by Region, 2018 and 2026
  • Figure 2 : Global Metastatic Bone Disease Market Value Share, by Origin of Metastasis (2017)
  • Figure 3 : Global Metastatic Bone Disease Market Value Share, by Treatment (2017)
  • Figure 4 : Global Metastatic Bone Disease Market Value Share, by End-user (2017)
  • Figure 5 : Global Metastatic Bone Disease Market Value Share, by Region (2017)
  • Figure 6 : Global Metastatic Bone Disease Market Value (US$ Mn) Forecast, 2016–2026
  • Figure 7 : Global Metastatic Bone Disease Market Value Share (%), by Treatment, 2018 and 2026
  • Figure 8 : Global Metastatic Bone Disease Market Revenue (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, by Medication, 2016–2026
  • Figure 9 : Global Metastatic Bone Disease Market Revenue (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, by Radiation Therapy, 2016–2026
  • Figure 10 : Global Metastatic Bone Disease Market Revenue (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, by Surgical Intervention, 2016–2026
  • Figure 11 : Global Metastatic Bone Disease Market Revenue (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, by Tumor Ablation Therapy, 2016–2026
  • Figure 12 : Global Metastatic Bone Disease Market Attractiveness, by Treatment, 2017–2025
  • Figure 13 : Global Metastatic Bone Disease Market Value Share (%), by Origin of Metastasis, 2018 and 2026
  • Figure 14 : Global Metastatic Bone Disease Market Revenue (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, by Breast Cancer, 2016–2026
  • Figure 15 : Global Metastatic Bone Disease Market Revenue (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, by Lung Cancer, 2016–2026
  • Figure 16 : Global Metastatic Bone Disease Market Revenue (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, by Thyroid Cancer, 2016–2026
  • Figure 17 : Global Metastatic Bone Disease Market Revenue (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, by Kidney Cancer, 2016–2026
  • Figure 18 : Global Metastatic Bone Disease Market Revenue (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, by Prostate Cancer, 2016–2026
  • Figure 19 : Global Metastatic Bone Disease Market Revenue (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, by Others, 2016–2026
  • Figure 20 : Global Metastatic Bone Disease Market Attractiveness, by Origin of Metastasis, 2018–2026
  • Figure 21 : Global Metastatic Bone Disease Market Value Share (%), by End-user, 2018 and 2026
  • Figure 22 : Global Metastatic Bone Disease Market Revenue (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, by Hospitals, 2016–2026
  • Figure 23 : Global Metastatic Bone Disease Market Revenue (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, by Specialty Clinics, 2016–2026
  • Figure 24 : Global Metastatic Bone Disease Market Revenue (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, by Ambulatory Surgical Centers, 2016–2026
  • Figure 25 : Global Metastatic Bone Disease Market Attractiveness, by End-user, 2018–2026
  • Figure 26 : Global Metastatic Bone Disease Market Value Share (%), by Region, 2018 and 2026
  • Figure 27 : Global Metastatic Bone Disease Market Attractiveness, by Region, 2018–2026
  • Figure 28 : North America Metastatic Bone Disease Market Revenue (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2016–2026
  • Figure 29 : North America Metastatic Bone Disease Market Value Share (%), by Country, 2018 and 2026
  • Figure 30 : North America Metastatic Bone Disease Market Attractiveness, by Country, 2018–2026
  • Figure 31 : North America Metastatic Bone Disease Market Value Share (%), by Treatment, 2018 and 2026
  • Figure 32 : North America Metastatic Bone Disease Market Attractiveness, by Treatment, 2018–2026
  • Figure 33 : North America Metastatic Bone Disease Market Value Share (%), by Origin of Metastasis, 2018 and 2026
  • Figure 34 : North America Metastatic Bone Disease Market Attractiveness, by Origin of Metastasis, 2018–2026
  • Figure 35 : North America Metastatic Bone Disease Market Value Share (%), by End-user, 2018 and 2026
  • Figure 36 : North America Metastatic Bone Disease Market Attractiveness, by End-user, 2018–2026
  • Figure 37 : Europe Metastatic Bone Disease Market Revenue (US$ Mn) Forecast and Y-o-Y Growth Projection (%), 2016–2026
  • Figure 38 : Europe Metastatic Bone Disease Market Value Share (%), by Country/Sub-region, 2018 and 2026
  • Figure 39 : Europe Metastatic Bone Disease Market Attractiveness, by Country/Sub-region, 2018–2026
  • Figure 40 : Europe Metastatic Bone Disease Market Value Share (%), by Treatment, 2018 and 2026
  • Figure 41 : Europe Metastatic Bone Disease Market Attractiveness, by Treatment, 2018–2026
  • Figure 42 : Europe Metastatic Bone Disease Market Value Share (%), by Origin of Metastasis, 2018 and 2026
  • Figure 43 : Europe Metastatic Bone Disease Market Attractiveness, by Origin of Metastasis, 2018–2026
  • Figure 44 : Europe Metastatic Bone Disease Market Value Share (%), by End-user, 2018 and 2026
  • Figure 45 : Europe Metastatic Bone Disease Market Attractiveness, by End-user, 2018–2026
  • Figure 46 : Asia Pacific Metastatic Bone Disease Market Revenue (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2016–2026
  • Figure 47 : Asia Pacific Metastatic Bone Disease Market Value Share (%), by Country/Sub-region, 2018 and 2026
  • Figure 48 : Asia Pacific Metastatic Bone Disease Market Attractiveness, by Country/Sub-region, 2018–2026
  • Figure 49 : Asia Pacific Metastatic Bone Disease Market Value Share (%), by Treatment, 2018 and 2026
  • Figure 50 : Asia Pacific Metastatic Bone Disease Market Attractiveness, by Treatment, 2018–2026
  • Figure 51 : Asia Pacific Metastatic Bone Disease Market Value Share (%), by Origin of Metastasis, 2018 and 2026
  • Figure 52 : Asia Pacific Metastatic Bone Disease Market Attractiveness, by Origin of Metastasis, 2018–2026
  • Figure 53 : Asia Pacific Metastatic Bone Disease Market Value Share (%), by End-user, 2018 and 2026
  • Figure 54 : Asia Pacific Metastatic Bone Disease Market Attractiveness, by End-user, 2018–2026
  • Figure 55 : Latin America Metastatic Bone Disease Market Revenue (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2016–2026
  • Figure 56 : Latin America Metastatic Bone Disease Market Value Share (%), by Country/Sub-region, 2018 and 2026
  • Figure 57 : Latin America Metastatic Bone Disease Market Attractiveness, by Country/Sub-region, 2018–2026
  • Figure 58 : Latin America Metastatic Bone Disease Market Value Share (%), by Treatment, 2018 and 2026
  • Figure 59 : Latin America Metastatic Bone Disease Market Attractiveness, by Treatment, 2018–2026
  • Figure 60 : Latin America Metastatic Bone Disease Market Value Share (%), by Origin of Metastasis, 2018 and 2026
  • Figure 61 : Latin America Metastatic Bone Disease Market Attractiveness, by Origin of Metastasis, 2018–2026
  • Figure 62 : Latin America Metastatic Bone Disease Market Value Share (%), by End-user, 2018 and 2026
  • Figure 63 : Latin America Metastatic Bone Disease Market Attractiveness, by End-user, 2018–2026
  • Figure 64 : Middle East & Africa Metastatic Bone Disease Market Revenue (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2016–2026
  • Figure 65 : Middle East & Africa Metastatic Bone Disease Market Value Share (%), by Country/Sub-region, 2018 and 2026
  • Figure 66 : Middle East & Africa Metastatic Bone Disease Market Attractiveness, by Country/Sub-region, 2018–2026
  • Figure 67 : Middle East & Africa Metastatic Bone Disease Market Value Share (%), by Treatment, 2018 and 2026
  • Figure 68 : Middle East & Africa Metastatic Bone Disease Market Attractiveness, by Treatment, 2018–2026
  • Figure 69 : Middle East & Africa Metastatic Bone Disease Market Value Share (%), by Origin of Metastasis, 2018 and 2026
  • Figure 70 : Middle East & Africa Metastatic Bone Disease Market Attractiveness, by Origin of Metastasis, 2018–2026
  • Figure 71 : Middle East & Africa Metastatic Bone Disease Market Value Share (%), by End-user, 2018 and 2026
  • Figure 72 : Middle East & Africa Metastatic Bone Disease Market Attractiveness, by End-user, 2018–2026
  • Figure 73 : Market Share of Prominent Key Players: Metastatic Bone Disease Market, 2017

Leaders in analytics, research and advisory services for Fortune 500 companies, scores of high potential startups, and financial institutions. Our success stories have proven why we are a prominent provider of a cutting-edge syndicated and customized research services. Leverage the best of our seasoned research analysts who had a keen interest and enviable expertise of almost 4 million hours in global, regional, and local market intelligence.

Why BCC Research?

Every purchase provides access to:

  • Thousands of recently published reports from select publishers
  • Member Discounts of up to 50% on over 20,000 additional reports from all publishers
  • Our analysts and research concierge for all inquiries
CUSTOM RESEARCH

Need a custom data table, graph or complete report? Tell us more.

Contact Us
Share This Report